Dissecting HDAC3-mediated tumor progression

Por Mariadason, John M.
Publicado em 2008

Making Sense of HDAC2 Mutations in Colon Cancer

Por MARIADASON, JOHN M.
Publicado em 2008

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer

Por Pereira, Lloyd, Mariadason, John M., Hannan, Ross D., Dhillon, Amardeep S.
Publicado no Front Oncol (2015)

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Por Chueh, Anderly C., Tse, Janson W.T., Tögel, Lars, Mariadason, John M.
Publicado no Antioxid Redox Signal (2015)

Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer

Por Wang, Donghai, Peregrina, Karina, Dhima, Elena, Lin, Elaine Y., Mariadason, John M., Augenlicht, Leonard H.
Publicado em 2011

Prediction and Testing of Biological Networks Underlying Intestinal Cancer

Por Patel, Vishal N., Bebek, Gurkan, Mariadason, John M., Wang, Donghai, Augenlicht, Leonard H., Chance, Mark R.
Publicado em 2010

By moonlighting in the nucleus, villin regulates epithelial plasticity

Por Patnaik, Srinivas, George, Sudeep P., Pham, Eric, Roy, Swati, Singh, Kanchan, Mariadason, John M., Khurana, Seema
Publicado no Mol Biol Cell (2016)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

Por Tutuka, Candani S. A., Andrews, Miles C., Mariadason, John M., Ioannidis, Paul, Hudson, Christopher, Cebon, Jonathan, Behren, Andreas
Publicado no Mol Cancer (2017)

Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan

Por Maitra, Radhashree, Seetharam, Raviraja, Tesfa, Lydia, Augustine, Titto A., Klampfer, Lidija, Coffey, Matthew C., Mariadason, John M., Goel, Sanjay
Publicado em 2014

Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT

Por Paroder, Viktoriya, Spencer, Shelly R., Paroder, Monika, Arango, Diego, Schwartz, Simo, Mariadason, John M., Augenlicht, Leonard H., Eskandari, Sepehr, Carrasco, Nancy
Publicado em 2006

Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity

Por Ung, Nelson, Putoczki, Tracy L, Stylli, Stanley S, Ng, Irvin, Mariadason, John M, Chan, Timothy A, Zhu, Hong-Jian, Luwor, Rodney B
Publicado em 2014

PTEN GENE EXPRESSION AND MUTATIONS IN THE PIK3CA GENE AS PREDICTORS OF CLINICAL BENEFIT TO ANTI EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY THERAPY IN PATIENTS WITH KRAS WILD TYPE ME...

Por Sood, Arjun, McClain, Danielle, Maitra, Radhashree, Basu-Mallick, Atrayee, Seetharam, Raviraja, Kaubisch, Andreas, Rajdev, Lakshmi, Mariadason, John M., Tanaka, Kathryn, Goel, Sanjay
Publicado em 2012

Altered Dynamics of Intestinal Cell Maturation in Apc(1638N/+) Mice

Por Wang, Donghai, Pezo, Rossanna C., Corner, Georgia, Sison, Cristina, Lesser, Martin L., Shenoy, Shailesh M., Mariadason, John M., Singer, Robert H., Augenlicht, Leonard H.
Publicado em 2010

K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines

Por Yeung, Yvonne, Lau, David K., Chionh, Fiona, Tran, Hoanh, Tse, Janson W. T., Weickhardt, Andrew J., Nikfarjam, Mehrdad, Scott, Andrew M., Tebbutt, Niall C., Mariadason, John M.
Publicado no Mol Oncol (2017)

HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21

Por Wilson, Andrew J., Byun, Do-Sun, Nasser, Shannon, Murray, Lucas B., Ayyanar, Kanyalakshmi, Arango, Diego, Figueroa, Maria, Melnick, Ari, Kao, Gary D., Augenlicht, Leonard H., Mariadason, John M.
Publicado em 2008

Intravenous administration of Reolysin(®), a live replication competent RNA virus is safe in patients with advanced solid tumors

Por Gollamudi, Radharani, Ghalib, Mohammad H., Desai, Kavita K., Chaudhary, Imran, Wong, Benny, Einstein, Mark, Coffey, Matthew, Gill, George M., Mettinger, Karl, Mariadason, John M., Mani, Sridhar, Goel, Sanjay
Publicado em 2009

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.

Por Tan, BeeShin, Anaka, Matthew, Deb, Siddhartha, Freyer, Claudia, Ebert, Lisa M., Chueh, Anderly C., Al-Obaidi, Sheren, Behren, Andreas, Jayachandran, Aparna, Cebon, Jonathan, Chen, Weisan, Mariadason, John M.
Publicado em 2013

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

Por Chüeh, Anderly C., Liew, Mun-Sem, Russell, Prudence A., Walkiewicz, Marzena, Jayachandran, Aparna, Starmans, Maud H.W., Boutros, Paul C., Wright, Gavin, Barnett, Stephen A, Mariadason, John M., John, Thomas
Publicado no Oncotarget (2017)

PIK3CA mutation / PTEN expression status predicts response of colon cancer cells to the EGFR inhibitor cetuximab

Por Jhawer, Minaxi, Goel, Sanjay, Wilson, Andrew J., Montagna, Cristina, Ling, Yi-He, Byun, Do-Sun, Nasser, Shannon, Arango, Diego, Shin, Joongho, Klampfer, Lidija, Augenlicht, Leonard H., Soler, Roman Perez, Mariadason, John M.
Publicado em 2008

Intestinal epithelial-specific PTEN inactivation results in tumor formation

Por Byun, Do-Sun, Ahmed, Naseem, Nasser, Shannon, Shin, Joongho, Al-Obaidi, Sheren, Goel, Sanjay, Corner, Georgia A., Wilson, Andrew J., Flanagan, Dustin J., Williams, David S., Augenlicht, Leonard H., Vincan, Elizabeth, Mariadason, John M.
Publicado em 2011